Antibodies to Two Oral Bacteria in Your Patient's Bloodstream May drive More Than Twenty Systemic Inflammatory Conditions

Antibodies to Two Oral Bacteria in Your Patient's Bloodstream May drive More Than Twenty Systemic Inflammatory Conditions

By Robyn Puglia, IFMCP,

While the importance of the oral-systemic connection is becoming better known, there is still a reflex to think quite locally about periodontal disease or the oral microbiome. More as an indirect driver of inflammation or in relation to how it affects the gut microbiome.

That framing understates what is actually happening. Oral dysbiosis or even inflamed, ulcerated gum tissue does not just generate local cytokines. It creates a physical breach, sometimes referred to as leaky gums, through which live bacteria themselves cross directly into the systemic circulation. This is bacteraemia, not just bystander inflammation, and it is the reason antibodies to specific oral organisms are worth measuring in blood rather than relying only on oral microbiome panels (as valuable as they clearly are).

A 2024 comprehensive review synthesising 252 studies on oral pathogens found that individuals with periodontitis or dental caries were, on average, 3.3 times more likely to develop a systemic disease or adverse pregnancy outcome, with a range up to 7.5 times depending on the condition. The systemic diseases and disorders linked to these oral organisms in the published literature span more than twenty distinct categories, including cardiovascular disease, diabetes, rheumatoid arthritis, lupus, other autoimmune conditions, inflammatory bowel disease, respiratory disease, liver disease, kidney disease, dementia and Alzheimer's disease, adverse pregnancy outcomes, and several cancers. Porphyromonas gingivalis and Streptococcus mutans were both named among the most frequently implicated organisms across this literature.

The mechanism behind this breadth of association was mapped out in an earlier, foundational review, which proposed that oral infection reaches distant tissues through three separate routes: metastatic spread of infection via transient bacteraemia, metastatic injury from circulating bacterial toxins, and metastatic inflammation from the immune response these organisms provoke once they are established elsewhere in the body. The first of these, live bacteria physically travelling through the bloodstream, is the one most easily missed in clinical practice, because it does not require ongoing gum disease symptoms to be relevant. Once P. gingivalis or S. mutans has crossed into circulation, its antigens can continue to provoke an antibody response and contribute to distant tissue pathology long after the gums themselves look unremarkable.

For P. gingivalis specifically, this systemic presence has a further consequence. The organism produces its own peptidylarginine deiminase, an enzyme capable of citrullinating both bacterial and human proteins once it is circulating in blood or lodged in distant tissue, giving it a direct route into the same citrullination pathway implicated in rheumatoid arthritis. S. mutans, meanwhile, is recognised for producing antibodies that cross react with human cardiac tissue once the organism has disseminated beyond the mouth.

The clinical implication is that measuring antibodies to these organisms in serum tells you something a local oral examination or assessment cannot: whether these bacteria have already breached the oral barrier and are engaging the systemic immune system elsewhere in the body. A patient with unexplained systemic inflammation, cardiovascular risk, or autoimmune features deserves to have this assessed directly rather than inferred from the state of their gums.

Array 12 includes both Porphyromonas gingivalis and Streptococcus mutans as distinct systemic antibodies for exactly this reason: gum disease is not only a local mucosal event, it is a documented route of entry for bacteria into the bloodstream, with consequences reaching far beyond the mouth.

References

  1. Murray PE, Coffman JA, Garcia-Godoy F. Oral pathogens' substantial burden on cancer, cardiovascular diseases, Alzheimer's, diabetes, and other systemic diseases: a public health crisis, a comprehensive review. Pathogens. 2024;13(12):1084.
  2. Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev. 2000;13(4):547-558.
  3. Jenning M, Marklein B, Ytterberg J, Zubarev RA, Joshua V, van Schaardenburg D, van de Stadt L, Catrina AI, Nonhoff U, Häupl T, Konthur Z, Burmester GR, Skriner K. Bacterial citrullinated epitopes generated by Porphyromonas gingivalis infection, a missing link for ACPA production. Ann Rheum Dis. 2020;79(9):1194-1202.